Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions
Epilepsy, Partial
Interventions
DRUG

Pregabalin

dose 150-600 mg/day given BID

DRUG

Lamotrigine

dose 100-500 mg/day given BID

Trial Locations (102)

0

Pfizer Investigational Site, Bogota

24

Pfizer Investigational Site, Tallaght

112

Pfizer Investigational Site, Taipei

1070

Pfizer Investigational Site, Brussels

1113

Pfizer Investigational Site, Sofia

1145

Pfizer Investigational Site, Budapest

1309

Pfizer Investigational Site, Sofia

1524

Pfizer Investigational Site, Sofia

2629

Pfizer Investigational Site, Lillehammer

3000

Pfizer Investigational Site, Leuven

4000

Pfizer Investigational Site, Plovdiv

4400

Pfizer Investigational Site, Nyíregyháza

7006

Pfizer Investigational Site, Trondheim

8000

Pfizer Investigational Site, Bruges

9010

Pfizer Investigational Site, Varna

9023

Pfizer Investigational Site, Győr

10138

Pfizer Investigational Site, Tallinn

10365

Pfizer Investigational Site, Berlin

10400

Pfizer Investigational Site, Rajthevee

Pfizer Investigational Site, Bangkok

11461

Pfizer Investigational Site, Bucharest

14000

Pfizer Investigational Site, Mexico City

17007

Pfizer Investigational Site, Girona

28040

Pfizer Investigational Site, Madrid

33076

Pfizer Investigational Site, Bordeaux

33520

Pfizer Investigational Site, Tampere

40002

Pfizer Investigational Site, Muang

40139

Pfizer Investigational Site, Bologna

45147

Pfizer Investigational Site, Essen

46009

Pfizer Investigational Site, Valencia

46014

Pfizer Investigational Site, Valencia

50009

Pfizer Investigational Site, Kaunas

50125

Pfizer Investigational Site, Florence

51014

Pfizer Investigational Site, Tartu

53105

Pfizer Investigational Site, Bonn

54035

Pfizer Investigational Site, Nancy

56126

Pfizer Investigational Site, Pisa

60528

Pfizer Investigational Site, Frankfurt

67091

Pfizer Investigational Site, Strasbourg

70210

Pfizer Investigational Site, Kuopio

71100

Pfizer Investigational Site, Foggia

75185

Pfizer Investigational Site, Uppsala

78223

Pfizer Investigational Site, San Luis Potosí City

82606

Pfizer Investigational Site, Bratislava

89075

Pfizer Investigational Site, Ulm

89081

Pfizer Investigational Site, Ulm

169608

Pfizer Investigational Site, Singapore

300052

Pfizer Investigational Site, Tianjin

400012

Pfizer Investigational Site, Cluj-Napoca

400016

Pfizer Investigational Site, Chongqing

452001

Pfizer Investigational Site, Indore

610041

Pfizer Investigational Site, Cheng Du Si Chaun

710032

Pfizer Investigational Site, Xi’an

Unknown

Pfizer Investigational Site, Santiago de Cali

Pfizer Investigational Site, Hong Kong

Pfizer Investigational Site, Kowloon

Pfizer Investigational Site, Shatin

Pfizer Investigational Site, Tainan City

Pfizer Investigational Site, Taipei

602 00

Pfizer Investigational Site, Brno

500 05

Pfizer Investigational Site, Hradec Králové

708 58

Pfizer Investigational Site, Ostrava

393 01

Pfizer Investigational Site, Pelhřimov

140 59

Pfizer Investigational Site, Prague

516 01

Pfizer Investigational Site, Rychnov nad Kněžnou

760 01

Pfizer Investigational Site, Zlín

560 054

Pfizer Investigational Site, Bangalore

600 006

Pfizer Investigational Site, Chennai

560 034

Pfizer Investigational Site, Bangalore

226 014

Pfizer Investigational Site, Lucknow

110 002

Pfizer Investigational Site, New Delhi

LV 1002

Pfizer Investigational Site, Riga

LV 1038

Pfizer Investigational Site, Riga

03215

Pfizer Investigational Site, Vilnius

08661

Pfizer Investigational Site, Vilnius

2512 VA

Pfizer Investigational Site, The Hague

2700-276

Pfizer Investigational Site, Amadora

3000-548

Pfizer Investigational Site, Coimbra

3040-853 Coimbra

Pfizer Investigational Site, Coimbra

4099-001

Pfizer Investigational Site, Porto

4200-319

Pfizer Investigational Site, Porto

050098

Pfizer Investigational Site, Bucharest

813 69

Pfizer Investigational Site, Bratislava

833 05

Pfizer Investigational Site, Bratislava

04015

Pfizer Investigational Site, Košice

012 07

Pfizer Investigational Site, Žilina

301-721

Pfizer Investigational Site, Daejeon

501-757

Pfizer Investigational Site, Gwangju

405-760

Pfizer Investigational Site, Incheon

110-744

Pfizer Investigational Site, Seoul

120-752

Pfizer Investigational Site, Seoul

134-701

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

137-701

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

08916

Pfizer Investigational Site, Badalona

413 45

Pfizer Investigational Site, Gothenburg

581 85

Pfizer Investigational Site, Linköping

ST4 7LN

Pfizer Investigational Site, Stoke-on-Trent

G11 6NT

Pfizer Investigational Site, Glasgow

L9 7LJ

Pfizer Investigational Site, Liverpool

TR1 3LJ

Pfizer Investigational Site, Treliske, Truro, Cornwall

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00280059 - Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy | Biotech Hunter | Biotech Hunter